TRAVERE THERAPEUTICS INC (TVTX) Stock Income Statement
NASDAQ:TVTX - Nasdaq - US89422G1076 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 273.53M | 233.18M | 145.24M | 212.00M | 227.50M | |||
| Cost Of Goods | 10.92M | 7.74M | 11.45M | 7.60M | 6.80M | |||
| Gross Profit | 262.61M | 225.43M | 133.79M | 204.40M | 220.70M | |||
| Operating Expenses | 487.70M | 481.62M | 510.53M | 471.00M | 382.50M | |||
| Research and Development | 214.97M | 217.50M | 237.73M | 229.50M | 209.20M | |||
| Selling, General, and Administrative Expenses | 227.95M | 222.38M | 236.52M | 195.50M | 126.10M | |||
| Operating Income | -225.09M | -256.18M | -376.74M | -266.50M | -161.80M | |||
| Interest Income/Expense | 4.34M | 6.63M | 10.43M | -5.00M | -18.10M | |||
| Other Income/Expense | -3.01M | -3.32M | 1.59M | 1.00M | 200.00K | |||
| Non Recurring Items | -2.18M | -67.64M | -11.39M | -7.60M | N/A | |||
| Income Before Taxes | -225.93M | -320.51M | -376.11M | -278.20M | -179.70M | |||
| Income Tax | -32.00K | 120.00K | 223.00K | 300.00K | 400.00K | |||
| Net Income | -226.71M | -321.55M | -111.40M | -278.50M | -180.10M | |||
| EBITDA | -178.61M | -212.63M | -338.21M | -233.42M | -135.18M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.79 | -4.06 | -1.49 | -4.37 | -3.01 | |||
| Non GAAP EPS | -2.81 | -4.10 | -4.60 | -4.37 | -3.03 | |||
| Statistics | ||||||||
| Gross Profit Margin | 96.01% | 96.68% | 92.12% | 96.42% | 97.01% | |||
| Profit Margin | -82.88% | -137.90% | -76.70% | -131.37% | -79.16% | |||
| Operating Profit Margin | -82.29% | -109.87% | -259.40% | -125.71% | -71.12% | |||
All data in USD